famotidine has been researched along with methylprednisolone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broughton, G | 1 |
| Hanaki, C; Kawaguchi, R; Maekawa, T; Nakagawa, M; Nakao, M; Nakatani, K; Suyama, H | 1 |
| Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M | 1 |
| Baer, AB; Holstege, CP; Wu, J | 1 |
| Doshi, AB; Jack, RL; Moshfeghi, DM | 1 |
| Bettge, AM; Gross, GN | 1 |
| Biebl, M; Brezinka, C; Mitterschiffthaler, G; Paal, P; Pallua, K; Putz, G | 1 |
| Awan, FT; Clemmons, AB; Hartranft, ME; Jillella, AP; Kota, V; Pantin, J; Salman, H | 1 |
| Droege, C; Kneale, H; Pahs, L; Pancioli, A | 1 |
| Blaziene, A; Chomiciene, A; Malinauskiene, L; Vebriene, R | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for famotidine and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for famotidine and methylprednisolone
| Article | Year |
|---|---|
Management of the brown recluse spider bite to the glans penis.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Calcium Gluconate; Dapsone; Diphenhydramine; Famotidine; Histamine Antagonists; Humans; Hyperbaric Oxygenation; Male; Methylprednisolone; Penis; Spider Bites | 1996 |
[A case of life-threatening anaphylactoid reaction caused by povidone-iodine].
Topics: Anaphylaxis; Anesthesia, General; Coronary Artery Bypass; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyzine; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Povidone-Iodine; Premedication | 1997 |
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.
Topics: Acute Disease; Acute Kidney Injury; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Bronchitis; C-Reactive Protein; Cefdinir; Cephalosporins; Creatinine; Disease Progression; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Kidney; Kidney Function Tests; Methylprednisolone; Middle Aged; Nephritis, Interstitial; Ofloxacin; Prednisolone; Radionuclide Imaging | 2001 |
Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae polyvalent immune Fab (ovine).
Topics: Adolescent; Anti-Inflammatory Agents; Antivenins; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Immediate; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Male; Methylprednisolone; Snake Bites | 2002 |
Anaphylactoid reaction after verteporfin therapy.
Topics: Aged, 80 and over; Anaphylaxis; Diphenhydramine; Drug Therapy, Combination; Famotidine; Female; Fluorescein Angiography; Humans; Macular Degeneration; Methylprednisolone; Photochemotherapy; Photosensitizing Agents; Porphyrins; Verteporfin | 2005 |
A serum sickness-like reaction to a commonly used acne drug.
Topics: Acne Vulgaris; Adult; Anti-Allergic Agents; Anti-Bacterial Agents; Diphenhydramine; Epinephrine; Famotidine; Female; Humans; Methylprednisolone; Minocycline; Prednisone; Risk Factors; Serum Sickness; Triamcinolone | 2008 |
Management of hepatic echinococcosis in pregnancy.
Topics: Adult; Albendazole; Cesarean Section; Diphenhydramine; Echinococcosis, Hepatic; Famotidine; Female; Hepatectomy; Humans; Live Birth; Methylprednisolone; Pregnancy; Pregnancy Complications, Parasitic | 2010 |
Administration of anti-thymocyte globulin: a comparison of two protocols.
Topics: Adult; Aged; Animals; Antilymphocyte Serum; Diphenhydramine; Drug Administration Schedule; Famotidine; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Pilot Projects; Rabbits; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2014 |
A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
Topics: Aged; Angioedema; Anti-Inflammatory Agents; Diphenhydramine; Drug Therapy, Combination; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Injections, Intravenous; Male; Methylprednisolone; Mouth Diseases; Tissue Plasminogen Activator; Tongue Diseases | 2016 |
Premedication for cold induced urticaria in a patient undergoing cold cardioplegia.
Topics: Aged; Cold Temperature; Diphenhydramine; Famotidine; Heart Arrest, Induced; Humans; Intraoperative Care; Male; Methylprednisolone; Postoperative Care; Premedication; Preoperative Care; Ranitidine; Urticaria | 2019 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |